CD4+ Th1 lymphocytes expressing CXCR3 have been shown to be important for anti-tumor responses [41], [42], and the reduction in CXCR3+ cells probably mirrors a reduction of Th1 cells and CD8+ CTL in the tumor area [43], [44]. This evidence concerns the gene CXCR3 and neoplasm.